GSK plc (LON:GSK) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of GSK plc (LON:GSK) have been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is GBX 1,805.83 ($22.57).

Several analysts recently issued reports on GSK shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,850 ($23.12) price target on shares of GSK in a research report on Tuesday, September 3rd. JPMorgan Chase & Co. reissued an “underweight” rating on shares of GSK in a report on Wednesday, December 11th. Shore Capital reaffirmed a “buy” rating on shares of GSK in a research report on Wednesday, August 28th. Finally, Berenberg Bank lowered their price target on GSK from GBX 1,820 ($22.75) to GBX 1,600 ($20.00) and set a “buy” rating for the company in a research report on Friday, November 29th.

Insider Activity

In other news, insider Jonathan Symonds acquired 7,150 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The stock was bought at an average price of GBX 1,394 ($17.42) per share, with a total value of £99,671 ($124,573.18). Also, insider Elizabeth (Liz) McKee Anderson acquired 446 shares of the stock in a transaction that occurred on Monday, September 23rd. The stock was purchased at an average price of GBX 2,051 ($25.63) per share, for a total transaction of £9,147.46 ($11,432.90). Insiders acquired a total of 7,604 shares of company stock valued at $10,893,038 in the last ninety days. 1.61% of the stock is currently owned by insiders.

GSK Stock Performance

Shares of GSK opened at GBX 1,318.50 ($16.48) on Friday. The company has a debt-to-equity ratio of 123.04, a current ratio of 0.82 and a quick ratio of 0.73. GSK has a one year low of GBX 1,282.50 ($16.03) and a one year high of GBX 1,823.50 ($22.79). The stock has a 50-day moving average of GBX 1,390.68 and a 200-day moving average of GBX 1,511.92. The company has a market cap of £53.79 billion, a PE ratio of 1,166.81, a P/E/G ratio of 1.24 and a beta of 0.31.

GSK Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Thursday, January 9th. Shareholders of record on Thursday, November 14th will be given a GBX 15 ($0.19) dividend. The ex-dividend date of this dividend is Thursday, November 14th. This represents a yield of 1.03%. GSK’s dividend payout ratio is currently 5,309.73%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.